Open original FDA record ↗Recall record
- FDA identifier
- Z-1033-2015
- Company in FDA record
- Express Diagnostics Int'l., Inc.
- FDA classification date
- Jan 30, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
This recall has been initiated due to potential false positives results when using the test to screen for Ketamine. Use of this product may give incorrect screening results.
Source facts
- Action
- Consignees were sent an Express Diagnostic Int. Inc., "Urgent" Letter dated 11//21/2014. The letter described the problem and the product involved in the recall. It advised consignees to quarantine the product. If the product has been further distributed, consignees were advised to notify their customers at once, Consignees were requested to complete and return the "Acknowledgement Form" either via fax to 1-507-526-2252 or e-mail Quality@drugcheck.com. For questions consignees can contact Jackie Gale, Director of Quality Systems and Regulatory Affairs at 1-507-526-3951.
- Initiated
- 2014-11-21
- Root cause
- Nonconforming Material/Component
- Terminated
- 2019-05-14
- Distribution
- Worldwide Distribution -- US, including the states of CA, NY, MN, and SC; SWEDEN, CANADA, UNITED KINGDOM, and GUATEMALA.
- Recall number
- Z-1033-2015
- Recall status
- Terminated
- CDRH record ID
- 132104
- FDA classified
- 2015-01-30
- Recall event number
- 70008